Data as of Dec 19
| +0.45 / +0.21%|
The 19 analysts offering 12-month price forecasts for Allergan have a median target of 219.00, with a high estimate of 245.00 and a low estimate of 204.00. The median estimate represents a +3.00% increase from the last price of 212.63.
The current consensus among 24 polled investment analysts is to Hold stock in Allergan. This rating has held steady since December, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.